Catatonic schizophrenia and the use of memantine

Annals of Pharmacotherapy

Volumn 40, Issue 2, 2006, Pages 344-346

  Carpenter, Stacey S ^a   Hatchett, A Daniel ^b,c   Fuller, Matthew A ^b  

^a Heartland Behavioral Healthcare   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Catatonia; Catatonic schizophrenia; Memantine

Indexed keywords

4 AMINOBUTYRIC ACID; ARIPIPRAZOLE; DONEPEZIL; FLUOXETINE; GLUTAMATE RECEPTOR ANTAGONIST; LEVOTHYROXINE; LORAZEPAM; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENYTOIN;

AGED; ARTICLE; BEHAVIOR DISORDER; BODY POSTURE; CASE REPORT; CATATONIC SCHIZOPHRENIA; DRUG MECHANISM; FACIAL EXPRESSION; GAZE; HUMAN; IMMOBILIZATION; MALE; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; MUTISM; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREATMENT OUTCOME; VERBAL COMMUNICATION;

AGED; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; MALE; MEMANTINE; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA, CATATONIC; TREATMENT OUTCOME;

EID: 33144467786     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G297     Document Type: Article

References (15)

1. Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003;160:1233-41.
2. Stompe T, Ortwein-Swoboda G, Ritter K, Schanda H, Friedmann A. Are we witnessing the disappearance of catatonic schizophrenia? Compr Psychiatry 2002;43:167-74.
3. Rosebush PI, Hildebrand AM, Furlong BG, Mazurek MF. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990;51:357-62.
4. Ungvari GS, Chiu HF, Chow LY, Lau BS, Tang WK. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled crossover study. Psychopharmacology 1999;142:393-8.
5. Huang TL. Lorazepam and diazepam rapidly relieve catatonic signs in patients with schizophrenia. Psychiatry Clin Neurosci 2005;59:52-5.
6. Lee JW, Schwartz DL, Hallmayer J. Catatonia in a psychiatric intensive care facility: incidence and response to benzodiazepines. Ann Clin Psychiatry 2000;12:89-96.
7. Rosebush PI, Mazurek MF. Catatonia after benzodiazepine withdrawal. J Clin Psychopharmacol 1996;16:315-9.
8. Glover SG, Escalona R, Bishop J, Saldivia A. Catatonia associated with lorazepam withdrawal. Psychosomatics 1997;38:148-50.
9. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand 1996;93:129-36.
10. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
11. Northoff G, Eckert J, Fritze J. Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine. J Neurol Neurosurg Psychiatry 1997;62:404-6.
12. Northoff G, Lins H, Boker H, Danos P, Bogerts B. Therapeutic efficacy of N-methyl D-aspartate antagonist amantadine in febrile catatonia. J Clin Psychopharmacol 1999;19:484-6.
13. Peltz G, Pacific DM, Joviasky JA, Shatla A, Mehalic T. Seizures associated with memantine use. Am J Health Syst Pharm 2005;62:420-1.
14. Huey ED, Dustin IH, Overman GP, Mirza N, Sunderland T. Development of subtle psychotic symptoms with memantine: a case report. J Clin Psychiatry 66:658-9.
15. Thomas C. Memantine and catatonic schizophrenia (letter). Am J Psychiatry 2005;162:626.